# COMP-4 Supplementation and Brachial Artery FMD

> **NCT05595915** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of California, Los Angeles** · enrollment: 32 (actual)

## Conditions studied

- Aging
- Endothelial Dysfunction
- Senescence

## Interventions

- **DIETARY_SUPPLEMENT:** COMP-4

## Key facts

- **NCT ID:** NCT05595915
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-01
- **Primary completion:** 2025-11-22
- **Final completion:** 2025-11-22
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2026-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05595915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05595915, "COMP-4 Supplementation and Brachial Artery FMD". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05595915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
